Cytokine Inhibitors: Targeted therapies such as IL-6 inhibitors (e.g., tocilizumab) and TNF-α blockers have shown promise in reducing anxiety symptoms in patients with high inflammatory markers [81]. This evidence concerns the gene IL6 and Anxiety.